Kurin, Inc. Reports Record Revenue for 2022
The Californer/10227630

SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of the Kurin^® blood culture collection sets announced record revenues for 2022. Revenue growth in 2022 was dramatic, increasing over 60% over 2021 revenue.

"We are pleased with Kurin's success, as demonstrated by the impressive growth over 2021, which also saw a large revenue increase over the prior year," said Bob Rogers, CEO of Kurin, Inc. "Our fourth quarter revenue reflected our highest sales quarter by some distance and we are very well positioned for continued strong growth in 2023."

"In addition, we continue to roll out our proprietary Advance™ push-button needle, providing vertical integration that increases our shareholder value," said Mr. Rogers. "We continue to build upon the company's strong financial position and have accelerated our hiring to accommodate this growth."

Kurin's revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection.

More on The Californer

• Nieves Ministries Leads with Faith to Fortify Safety, Education, and Puerto Rican Culture in Colorado
• San Francisco Hometown Star Terri J. Vaughn Hits Streaming Highs in Tyler Perry Studios "She the People" on Netflix
• Study: 78% of US Workers Have Chronic Conditions Despite Falling Disability Claims
• Hollywood Burbank Airport Joins Living Advantage, Inc. at V.I.P. Career Match Day!
• California: Governor Newsom announces appointments 5.30.25

About Kurin, Inc.

Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.

Contacts

Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com

---

Show All News | Report Violation